>
pdufa.bio

safusidenib

Updated ยทnext FDA decision on the calendar

safusidenib is a Nuvation Bio Inc. program. Its next catalyst is a Readout in Mar 2027. Every date links its source.

NUVB catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Nuvation Bio Inc. (NUVB). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Mar 2027NUVB

Questions

When is safusidenib's next FDA decision or readout?

The next tracked catalyst for safusidenib is a Readout in Mar 2027.

What happened at safusidenib's most recent FDA decision?

No FDA decision for safusidenib is in our archive yet.

Who makes safusidenib?

Nuvation Bio Inc. (NUVB).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.